Article
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses
14 Dec 2023
Abstract excerpt
Whole-genome screens using CRISPR technologies are powerful tools to identify novel tumour suppressors as well as factors that impact responses of malignant cells to anti-cancer agents. Applying this methodology to lymphoma cells, we conducted a genome-wide screen to identify novel inhibitors of tumour expansion that are induced by the tumour suppressor TRP53. We discovered that the absence of Arrestin domain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
